Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

2-Methoxyestradiol, an Endogenous 17β-Estradiol Metabolite, Inhibits Microglial Proliferation and Activation via an Estrogen Receptor-Independent Mechanism.
TRPM4 mRNA expression levels in peripheral blood mononuclear cells from multiple sclerosis patients.
Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.
Cardiovascular adaptation in people with multiple sclerosis following a twelve week exercise programme suggest deconditioning rather than autonomic dysfunction caused by the disease Results from a randomized controlled trial.
Present and emerging therapies for multiple sclerosis.
Therapeutic Apheresis in Pediatric Patients with Acute CNS Inflammatory Demyelinating Disease.
Venous endothelial injury in central nervous system diseases.
Phagocytosis of Microglia in the Central Nervous System Diseases.
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica.
Weight status in persons with multiple sclerosis: implications for mobility outcomes.
Digestion products of the PH20 hyaluronidase inhibit remyelination.
Altered Effective Connectivity during a Processing Speed Task in Individuals with Multiple Sclerosis.
Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis.
Role of Glycine N-methyltransferase in The Regulation of T Cell Responses in Experimental Autoimmune Encephalomyelitis.
Trace elements in scalp hair samples from patients with relapsing-remitting multiple sclerosis.
Role of prolactin in B cell regulation in multiple sclerosis.
Correction: multiple sclerosis in the mount etna region: possible role of volcanogenic trace elements.
CX3CL1 is up-regulated in the rat hippocampus during memory-associated synaptic plasticity.
The protective effects of bioactive (RS)-glucoraphanin on the permeability of the mice blood-brain barrier following experimental autoimmune encephalomyelitis.
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?
Cognitive Reserve as a Useful Concept for Early Intervention Research in Multiple Sclerosis.
Demyelinating disease: Neurodegeneration distinguishes MS from NMO.
Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis.
Multimodal neurophysiological evaluation of primary progressive multiple sclerosis - An increasingly valid biomarker, with limits.
Genetic factors and multiple sclerosis in the Moroccan population: A role for HLA class II.

Pages